Inergetics Inc (MBTG) financial statements (2020 and earlier)

Company profile

Business Address 550 BROAD STREET
NEWARK, NJ 07102
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments000
Cash and cash equivalents000
Receivables00 
Inventory, net of allowances, customer advances and progress billings100
Inventory100
Prepaid expense00
Prepaid expense and other current assets1
Other undisclosed current assets042
Total current assets:253
Noncurrent Assets
Property, plant and equipment  0
Intangible assets, net (including goodwill)000
Goodwill00 
Intangible assets, net (excluding goodwill)000
Deposits noncurrent assets000
Other undisclosed noncurrent assets  (0)
Total noncurrent assets:010
TOTAL ASSETS:263
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:453
Accounts payable331
Accrued liabilities0  
Employee-related liabilities0  
Interest and dividends payable1  
Other undisclosed accounts payable and accrued liabilities022
Debt211
Derivative instruments and hedges, liabilities100
Due to related parties4  
Deferred revenue and credits 1 
Other undisclosed current liabilities143
Total current liabilities:12117
Noncurrent Liabilities
Long-term debt and lease obligation 00
Long-term debt, excluding current maturities 00
Liabilities, other than long-term debt 1 
Due to related parties 1 
Total noncurrent liabilities: 20
Total liabilities:12137
Temporary equity, carrying amount 97
Stockholders' equity
Stockholders' equity attributable to parent, including:(19)(16)(5)
Common stock000
Additional paid in capital736969
Accumulated deficit(93)(85)(81)
Other undisclosed stockholders' equity attributable to parent007
Other undisclosed stockholders' equity9 (7)
Total stockholders' equity:(10)(16)(12)
TOTAL LIABILITIES AND EQUITY:263

Income statement (P&L) ($ in millions)

12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
210
Cost of revenue
(Cost of Goods and Services Sold)
(1)(1)(0)
Gross profit:100
Operating expenses(7)(7)(6)
Other undisclosed operating income000
Operating loss:(7)(6)(6)
Nonoperating expense(2)(1)(1)
Investment income, nonoperating1(0)1
Interest and debt expense(1)(1)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes111
Loss from continuing operations before income taxes:(8)(8)(6)
Income tax benefit032
Net loss attributable to parent:(8)(4)(4)
Preferred stock dividends and other adjustments(1)(2)(1)
Net loss available to common stockholders, diluted:(9)(6)(5)

Comprehensive Income ($ in millions)

12/31/2014
12/31/2013
12/31/2012
Net loss:(8)(4)(4)
Comprehensive loss, net of tax, attributable to parent:(8)(4)(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: